[Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)].

S E Khat'kova O R Orlova D V Pokhabov V P Dygileva S A Novikov O A Pogoreltseva V S Shevchenko E A Nikolaev

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

Obtained results indicate the safety, good tolerability and efficacy of Relatox in patients with CD comparable to Botox and can be recomemded for using by practitioners.

Keyphrases

primary care
early onset
deep brain stimulation
double blind
cross sectional
clinical trial
randomized controlled trial
general practice
replacement therapy
smoking cessation